Published in Neurology on July 13, 1999
Decreased motor cortex γ-aminobutyric acid in amyotrophic lateral sclerosis. Neurology (2012) 1.64
Regional variations and the effects of age and gender on glutamate concentrations in the human brain. Magn Reson Imaging (2007) 1.20
Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI. Neurology (2002) 1.12
N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease. Adv Exp Med Biol (2006) 1.00
Combined MR spectroscopic imaging and diffusion tensor MRI visualizes corticospinal tract degeneration in amyotrophic lateral sclerosis. J Neurol (2004) 0.96
Measures and markers in amyotrophic lateral sclerosis. NeuroRx (2004) 0.96
Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord (2004) 0.96
Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol (2007) 0.95
25 years of neuroimaging in amyotrophic lateral sclerosis. Nat Rev Neurol (2013) 0.93
An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol (2013) 0.92
Simultaneous detection of resolved glutamate, glutamine, and gamma-aminobutyric acid at 4 T. J Magn Reson (2006) 0.92
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging (2014) 0.90
Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS. Neurology (2011) 0.89
Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology (2010) 0.89
What does imaging reveal about the pathology of amyotrophic lateral sclerosis? Curr Neurol Neurosci Rep (2015) 0.82
Clinical Trial Designs in Amyotrophic Lateral Sclerosis: Does One Design Fit All? Neurotherapeutics (2015) 0.81
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis. Neurotherapeutics (2016) 0.79
Memantine decreases hippocampal glutamate levels: a magnetic resonance spectroscopy study. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.79
Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation. Eur J Neurosci (2009) 0.78
Endomicroscopy and electromyography of neuromuscular junctions in situ. Ann Clin Transl Neurol (2014) 0.78
Altered cortical beta-band oscillations reflect motor system degeneration in amyotrophic lateral sclerosis. Hum Brain Mapp (2016) 0.77
Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis. Sci Rep (2016) 0.75
Evaluation of the efficacy of memantine in the treatment of fibromyalgia: study protocol for a doubled-blind randomized controlled trial with six-month follow-up. Trials (2013) 0.75
Treatment of amyotrophic lateral sclerosis--what is the next step? J Neurol (2000) 0.75
The genome sequence of Drosophila melanogaster. Science (2000) 74.32
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Rapid method for the radioisotopic analysis of gaseous end products of anaerobic metabolism. Appl Microbiol (1974) 10.43
A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology (2007) 5.86
Association of hydrogen metabolism with methanogenesis in Lake Mendota sediments. Appl Environ Microbiol (1977) 4.51
Driven polymer translocation through a narrow pore. Biophys J (1999) 3.84
Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology (2003) 3.82
The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol (1991) 3.73
Phase II/III randomized trial of TCH346 in patients with ALS. Neurology (2007) 3.22
Grain boundary scars and spherical crystallography. Science (2003) 3.03
The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA (1989) 3.03
Wish to die in end-stage ALS. Neurology (2005) 2.97
Comparison of intravenous ketorolac, meperidine, and both (balanced analgesia) for renal colic. Ann Emerg Med (1996) 2.96
Emergency department workplace interruptions: are emergency physicians "interrupt-driven" and "multitasking"? Acad Emerg Med (2000) 2.87
Study of 962 patients indicates progressive muscular atrophy is a form of ALS. Neurology (2009) 2.60
Inactivation of pea leaf chloroplastic and cytoplasmic glucose 6-phosphate dehydrogenases by light and dithiothreitol. Plant Physiol (1974) 2.47
Work interrupted: a comparison of workplace interruptions in emergency departments and primary care offices. Ann Emerg Med (2001) 2.47
Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study. Anesth Analg (2001) 2.35
The natural history of primary lateral sclerosis. Neurology (2006) 2.31
Review article: the management of hepatocellular carcinoma. Aliment Pharmacol Ther (2009) 2.31
Effect of noninvasive positive-pressure ventilation on survival in amyotrophic lateral sclerosis. Ann Intern Med (1997) 2.12
Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). Neurology (2004) 2.09
Characterization of the heat shock response and identification of heat shock protein antigens of Borrelia burgdorferi. Infect Immun (1990) 1.88
Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection. J Hepatol (1997) 1.82
Prevalence of depressive disorders and change over time in late-stage ALS. Neurology (2005) 1.80
Diversity and evolution of plant P450 and P450-reductases. Drug Metabol Drug Interact (1995) 1.76
A clinical trial of creatine in ALS. Neurology (2004) 1.73
Chloroquine neuromyotoxicity. Clinical and pathologic perspective. Am J Med (1987) 1.72
Brain tissue sodium is a ticking clock telling time after arterial occlusion in rat focal cerebral ischemia. Stroke (2000) 1.68
Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology (2000) 1.67
Pyrosequencing the Manduca sexta larval midgut transcriptome: messages for digestion, detoxification and defence. Insect Mol Biol (2009) 1.65
A randomized controlled trial of resistance exercise in individuals with ALS. Neurology (2007) 1.65
Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod (2002) 1.60
Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ. Radiology (1989) 1.59
Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron). Eur J Pharmacol (1989) 1.59
Pulling pinned polymers and unzipping DNA. Phys Rev Lett (2000) 1.57
Pilot study: fenofibrate for patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid. Aliment Pharmacol Ther (2010) 1.52
The reactive oxygen species-total antioxidant capacity score is a new measure of oxidative stress to predict male infertility. Hum Reprod (1999) 1.52
Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA (1997) 1.50
Growth of Vibrio anguillarum in Salmon Intestinal Mucus. Appl Environ Microbiol (1997) 1.49
The anti-viral effect of sorafenib in hepatitis C-related hepatocellular carcinoma. Aliment Pharmacol Ther (2012) 1.47
Physical therapy for a patient through six stages of amyotrophic lateral sclerosis. Phys Ther (1998) 1.42
The ALSFRSr predicts survival time in an ALS clinic population. Neurology (2005) 1.42
Ashkenazi-Jewish and non-Jewish adult GM2 gangliosidosis patients share a common genetic defect. Am J Hum Genet (1990) 1.40
Transport and localization of protein S, a spore coat protein, during fruiting body formation by Myxococcus xanthus. J Bacteriol (1983) 1.39
Intermittent esotropia associated with rippling muscle disease. J Neuroophthalmol (1995) 1.38
Subcellular localization and chaperone activities of Borrelia burgdorferi Hsp60 and Hsp70. J Bacteriol (1994) 1.37
Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology (2000) 1.37
Relationship between oxidative stress, semen characteristics, and clinical diagnosis in men undergoing infertility investigation. Fertil Steril (2000) 1.35
The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol (1991) 1.35
How do physicians and nurses spend their time in the emergency department? Ann Emerg Med (1998) 1.33
Novel defect structures in nematic liquid crystal shells. Phys Rev Lett (2007) 1.31
NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. Biochim Biophys Acta (1984) 1.31
Crystallography on curved surfaces. Proc Natl Acad Sci U S A (2006) 1.30
Localization of myxobacterial hemagglutinin in the periplasmic space and on the cell surface of Myxococcus xanthus during developmental aggregation. J Biol Chem (1981) 1.30
Relationship between seminal white blood cell counts and oxidative stress in men treated at an infertility clinic. J Androl (2001) 1.29
Modeling indoor air concentrations near emission sources in imperfectly mixed rooms. J Air Waste Manag Assoc (1996) 1.28
A two-stage design for a phase II clinical trial of coenzyme Q10 in ALS. Neurology (2006) 1.28
Structural studies of apolipoprotein A-I/phosphatidylcholine recombinants by high-field proton NMR, nondenaturing gradient gel electrophoresis, and electron microscopy. Biochemistry (1984) 1.27
Induction of protease activity in Vibrio anguillarum by gastrointestinal mucus. Appl Environ Microbiol (1999) 1.26
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma. Aliment Pharmacol Ther (2011) 1.21
Evidence for long-lived mRNA during fruiting body formation in myxococcus xanthus. Proc Natl Acad Sci U S A (1983) 1.17
Motor neuron disease and adult hexosaminidase A deficiency in two families: evidence for multisystem degeneration. Ann Neurol (1985) 1.17
Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology (Berl) (1987) 1.17
Clonal analysis of vertebrate myogenesis. IV. Medium-dependent classification of colony-forming cells. Dev Biol (1975) 1.17
Incorporation of substrate cell lipid A components into the lipopolysaccharide of intraperiplasmically grown Bdellovibrio bacteriovorus. J Bacteriol (1981) 1.17
Prehospital oral endotracheal intubation by rural basic emergency medical technicians. Ann Emerg Med (1998) 1.16
Inclusion body myositis presenting as treatment-resistant polymyositis. Arthritis Rheum (1987) 1.15
Pause point spectra in DNA constant-force unzipping. Biophys J (2005) 1.12
Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Neurology (2009) 1.11
Chemical and physical analyses of wax ester properties. J Insect Sci (2001) 1.10
Perineurioma as the cause of localized hypertrophic neuropathy. Muscle Nerve (1980) 1.10
An alternative method for fabrication of a closed hollow obturator. J Prosthet Dent (1986) 1.08
P450 gene nomenclature based on evolution. Methods Enzymol (1991) 1.08
Quality control of reactive oxygen species measurement by luminol-dependent chemiluminescence assay. J Androl (2001) 1.08
Nematic textures in spherical shells. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 1.08
Crystalline order on a sphere and the generalized Thomson problem. Phys Rev Lett (2002) 1.08
Chronic progressive external ophthalmoplegia (CPEO): clinical, morphologic, and biochemical studies. Neurology (1983) 1.08
Magnitude and regional distribution of cartilage loss associated with grades of joint space narrowing in radiographic osteoarthritis--data from the Osteoarthritis Initiative (OAI). Osteoarthritis Cartilage (2010) 1.07
Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry (2009) 1.07
Therapeutic response of breast carcinoma monitored by 31P MRS in situ. Magn Reson Med (1989) 1.06
Life and death near a windy oasis. J Math Biol (2000) 1.05
Transcranial magnetic stimulation in ALS: utility of central motor conduction tests. Neurology (2009) 1.04
Hand washing frequency in an emergency department. J Emerg Nurs (1994) 1.04
Laboratory investigation of deaths due to anaphylaxis. J Forensic Sci (1991) 1.04
Treatment of proximal hind-limb lameness in cattle. Vet Clin North Am Food Anim Pract (1985) 1.02
Intussusception in cattle: 336 cases (1964-1993). J Am Vet Med Assoc (1997) 1.02
Evolution of the cytochrome P450 genes. Xenobiotica (1989) 1.02
Association between postoperative hypothermia and adverse outcome after coronary artery bypass surgery. Ann Thorac Surg (2000) 1.01
Infectious bovine rhinotracheitis (Herpesvirus bovis) infection in swine. Am J Vet Res (1972) 1.01
Minimal size phosphatidylcholine vesicles: effects of radius of curvature on head group packing and conformation. Biochemistry (1982) 1.01
Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19. Pharmacogenetics (2001) 1.01
Varicocelectomy improves intrauterine insemination success rates in men with varicocele. J Urol (2001) 1.01
Cytochrome P450 1D1: a novel CYP1A-related gene that is not transcriptionally activated by PCB126 or TCDD. Arch Biochem Biophys (2008) 1.01
Probing the role of positive residues in the ADP/ATP carrier from yeast. The effect of six arginine mutations of oxidative phosphorylation and AAC expression. Biochemistry (1996) 1.00
Cuticular hydrocarbons ofReticulitermes virginicus (Banks) and their role as potential species- and caste-recognition cues. J Chem Ecol (1982) 1.00